| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.068 | 0.1 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.046 | 0.3 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.047 | 0.4 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.025 | 0.6 |